Craig Phillips, MD
Hand Surgery · Glenview, ILNPI 1588618516
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,270 of the $4,409 with a category attached, or 74.2%. Nextremity Solutions Inc. accounts for 77.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $3,354 and has fallen 97.2% since, to $94 in 2025.
Across 23 payments — averaging $191.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nextremity Solutions Inc.$3K
- Axogen$226
- Amgen$124
- Johnson & Johnson$103
- Acumed LLC$100
- Bioventus LLC$96
- plus $323 from 7 others
What the payments were for
- Consulting fees$3,27074%
- Food & beverage$1,13926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nextremity Solutions Inc. | 3 | $3,437 |
| Axogen | 3 | $226 |
| Amgen | 1 | $124 |
| Johnson & Johnson | 2 | $103 |
| Acumed LLC | 1 | $100 |
| Bioventus LLC | 2 | $96 |
| Stryker | 2 | $73 |
| Smith+Nephew | 1 | $66 |
| Endo Pharmaceuticals Inc. | 3 | $57 |
| Endo USA, Inc. | 2 | $52 |
| Osteomed LLC | 1 | $33 |
| Spinal Simplicity, LLC | 1 | $28 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,409 in reported general payments places this provider in the 65th percentile of 121 hand surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 176 | $943 |
| Meloxicam | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Glenview
- Leon BensonGlenview$62K
- Jeffrey VisotskyMorton Grove$1.1M
- Robert GraySkokie$422K
- Robert CoatsTinley Park$408K
- Randipsingh BindraMaywood$297K
- Jonathan TuetingAurora$190K
- Mark CohenChicago$78K
- Jeffrey StepanChicago$71K
- Debdut BiswasWarrenville$56K
- Eric PerezChicago$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.